Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor

Arthritis and Rheumatism

Volumn 43, Issue 2, 2000, Pages 250-258

  Gravallese, Ellen M ^a,d   Manning, Cathy ^a   Tsay, Alfie ^a   Naito, Akifumi ^a   Pan, Chin ^b   Amento, Edward ^b,c   Goldring, Steven R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Palo Alto Institute of Molecular Medicine   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; CATHEPSIN K; CD3 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR;

ARTICLE; BONE EROSION; CELL DIFFERENTIATION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LIGAND BINDING; MACROPHAGE FUNCTION; OSTEOCLAST; PANNUS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIUM;

EID: 0034122050     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P     Document Type: Article

References (38)

1. Van Zeben D, Hazes JM, Zwinderman AH, Vandenbroucke JP, Breedveld FC. Factors predicting outcome of rheumatoid arthritis: results of a followup study. J Rheumatol 1993;20:1288-96.
2. Woolley DE, Crossley MJ, Evanson JM. Collagenase at sites of cartilage erosion in the rheumatoid joint. Arthritis Rheum 1977; 20:1231-9.
3. Trabandt A, Gay RE, Fassbender H-G, Gay S. Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis. Arthritis Rheum 1991;34:1444-51.
4. Tetlow LC, Woolley DE. Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalization studies. Ann Rheum Dis 1995;54:896-903.
5. Holliday LS, Welgus HG, Fliszar CJ, Veith GM, Jeffrey JJ, Gluck SL. Initiation of osteoclast bone resorption by interstitial collagenase. J Biol Chem 1997;272:22053-8.
6. Bromley M, Woolley DE. Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint. Arthritis Rheum 1984;27:968-75.
7. Suda T, Takahashi N, Martin TJ. Modulation of osteoclast differentiation. Endocr Rev 1992;13:66-80.
8. Van de Wijngaert FP, Burger EH. Demonstration of tartrateresistant acid phosphatase in undecalcified, glycolmethacrylate-embedded mouse bone: a possible marker for (pre)osteoclast identification. J Histochem Cytochem 1986;34:1317-23.
9. Horton M. Current status review. Vitronectin receptor: tissue specific expression or adaptation to culture? Int J Exp Pathol 1990;71:741-59.
10. 3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells. Endocrinology 1988;123:1504-10.
11. Hattersley G, Chambers TJ. Calcitonin receptors as markers for osteoclastic differentiation: correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures. Endocrinology 1989;125:1606-12.
12. Lee SK, Goldring S, Lorenzo JA. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin. Endocrinology 1995;136:4572-81.
13. Gravallese EM, Harada Y, Wang J-T, Gorn AH, Thornhill TS, Goldring SR. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 1998;152:943-51.
14. Hattersley G, Chambers TJ. Generation of osteoclastic function in mouse bone marrow cultures: multinuclearity and tartrateresistant acid phosphatase are unreliable markers for osteoclastic differentiation. Endocrinology 1989;124:1689-96.
15. Chu CQ, Field M, Feldmann M, Maini RN. Localization of tumor necrosis factor α in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1125-32.
16. Delauren BW, Chu CQ, Field M, Brennan FM, Katsikis P, Feldmann M, et al. Localization of interleukin-1α type 1 interleukin 1 receptor and interleukin 1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. Br J Rheumatol 1992;31:801-9.
17. Romas E, Martin TJ. Cytokines in the pathogenesis of osteoporosis. Osteoporos Int 1997;Suppl 3:547-53.
18. Pollard JW, Stanley ER. Pleiotropic roles for CSF-1 in development defined by the mouse mutation osteopetrotic. In: Wassarman PM, editor. Advances in developmental biochemistry. Vol. 4. Stamford (CT): JAI Press Inc; 1996, p. 153-93.
19. Lacey DL, Timms E, Tan H-L, Kelley MJ, Dunstan CR, Burgess T, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-76.
20. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S-I, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 1998;95:3597-602.
21. Horwood NJ, Elliott J, Martin TJ, Gillespie MT. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 1998;139:4743-6.
22. Kong Y-Y, Yoshida H, Sarosi I, Tan H-L, Timms E, Capparelli C, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999;397: 315-23.
23. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
24. Goldring SR, Schiller AL, Roelke M, Rourke CM, O'Neill DA, Harris WH. The synovial-like membrane at the bone-cement interface in loose total hip replacements and in bone lysis. J Bone Joint Surg Am 1983;65-A:575-84.
25. Stamenkovic I, Stegagno M, Wright KA, Krane SM, Amento E, Colvin RB, et al. Clonal dominance among T-lymphocyte infiltrates in arthritis. Proc Natl Acad Sci U S A 1988;85:1179-83.
26. Littlewood-Evans A, Kokubo T, Ishibashi O, Inaoka T, Wlodarski B, Gallagher JA, et al. Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry. Bone 1997;20:81-6.
27. Li Y-P, Chen W. Characterization of mouse cathepsin K gene, the gene promoter and the gene expression. J Bone Miner Res 1999;14:487-99.
28. Hummel KM, Petrow PK, Franz JK, Muller-Ladner U, Aicher WK, Gay RE, et al. Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction. J Rheumatol 1998;25:1887-94.
29. Fujikawa Y, Sabokbar A, Neale S, Athanasou NA. Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis. Ann Rheum Dis 1996;55: 816-22.
30. Takayanagi H, Oda H, Yamamoto S, Kawaguchi H, Tanaka S, Nishikawa T, et al. A new mechanism of bone destruction in rheumatoid arthritis: synovial fibroblasts induce osteoclastogenesis. Biochem Biophys Res Commun 1997;240:279-86.
31. Dayer J-M, Krane SM, Russell RGG, Robinson DR. Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells. Proc Natl Acad Sci U S A 1976;73:945-9.
32. 2 and cyclic adenosine 3′,5′-monophosphate. Biochem Biophys Acta 1979;586:87-105.
33. Shimizu S, Shiozawa S, Shiozawa K, Imura S, Fujita T. Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis. Arthritis Rheum 1985;28:25-31.
34. Suzuki Y, Nishikaku F, Nakatuka M, Koga Y. Osteoclast-like cells in murine collagen induced arthritis. J Rheumatol 1998;25: 1154-60.
35. Kuratani T, Nagata K, Kukita T, Hotokebuchi T, Nakasima A, Lijima T. Induction of abundant osteoclast-like multinucleated giant cells in adjuvant arthritic rats with accompanying disordered high bone turnover. Histol Histopathol 1998;13:751-9.
36. Fujikawa Y, Shingu M, Torisu T, Itonaga I, Masumi S. Bone resorption by tartrate-resistant acid phosphatase-positive multinuclear cells isolated from rheumatoid synovium. Br J Rheumatol 1996;35:213-7.
37. Josien R, Wong BR, Li H-L, Steinman RM, Choi Y. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J Immunol 1999;162:2562-8.
38. Mizuno A, Amizuka N, Irie K, Murakami A, Fujise N, Kanno T, et al. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem Biophys Res Commun 1998;247:610-5.